Michael Sillers, MD
Otolaryngology · Birmingham, ALNPI 1205806213
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Neurent Medical Limited at 50.0% of the total. Reporting peaked in 2021 at $20,954 and has fallen 59.4% since, to $8,500 in 2025. Among otolaryngology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $215.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurent Medical Limited$26K
- Aerin Medical Inc.$20K
- Medtronic$2K
- Optinose US, Inc.$1K
- GSK$940
- Regeneron Healthcare Solutions, Inc.$787
- plus $2K from 15 others
Across 47 payments — averaging $7901.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurent Medical Limited$236K
- Aerin Medical Inc.$128K
- Spirair, Inc.$7K
What the payments were for
- Consulting fees$14,68828%
- Speaking & faculty fees$20,45039%
- Travel & lodging$12,00923%
- Food & beverage$5,41610%
- Education$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurent Medical Limited | 10 | $26,296 |
| Aerin Medical Inc. | 12 | $19,878 |
| Medtronic(2 entities) | 5 | $1,845 |
| Optinose US, Inc. | 73 | $1,049 |
| GSK | 48 | $940 |
| Regeneron Healthcare Solutions, Inc. | 31 | $787 |
| Sanofi | 23 | $598 |
| Stryker | 4 | $313 |
| Alk-abello, Inc | 13 | $298 |
| Intersect ENT, Inc. | 7 | $171 |
| AbbVie | 5 | $99 |
| Amgen | 3 | $82 |
| KARL Storz Endoscopy-america | 1 | $62 |
| Acclarent, Inc | 2 | $45 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Olympus America Inc. | 1 | $23 |
| Merck | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Ambu Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROMARK Radiofrequency Console$26,009
- VIVAER STYLUS$19,640
- RHINAER STYLUS$19,640
- NEUROMARK Device$18,776
- NEUROMARK System$7,348
- STRAIGHTSHOT$950
- FUSION$167
- XPRESS ENT DILATION SYSTEM$120
- NEUROMARK Radiofrequency Generator$116
How this compares
$52,596 in reported general payments places this provider in the 95th percentile of 155 otolaryngology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 41 | $153,626 |
| Dupixent PenDupilumab | 18 | $64,482 |
| Ipratropium Bromide | 212 | $7,045 |
| Fluticasone Propionate | 64 | $1,208 |
| Famotidine | 109 | $1,155 |
| Azelastine Hcl | 26 | $971 |
| Doxycycline Hyclate | 54 | $955 |
| Azithromycin | 29 | $554 |
| Omeprazole | 23 | $313 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $211 |
| Mupirocin | 30 | $142 |
| Ondansetron OdtOndansetron | 32 | $121 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $79 |
| Prednisone | 30 | $71 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Birmingham
- Justin TurnerBirmingham$34K
- Bradford WoodworthBirmingham$27K
- Patrick OwensBirmingham$26K
- Kirk WithrowBirmingham$22K
- Do-Yeon ChoBirmingham$19K
- Andrew FusonBirmingham$18K
- Benjamin GreeneBirmingham$15K
- William BarberBirmingham$13K
- Dennis PappasBirmingham$13K
- Ryan MarshallBirmingham$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.